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Any pathologic event in the brain leads to the activation of microglia, the immunocompetent cells of the
central nervous system. In recent decades diverse molecular pathways have been identified by which
microglial activation is controlled and by which the activated microglia affects neurons. In the normal brain
microglia were considered ‘‘resting,’’ but it has recently become evident that they constantly scan the brain
environment and contact synapses. Activated microglia can remove damaged cells as well as dysfunctional
synapses, a process termed ‘‘synaptic stripping.’’ Here we summarize evidence that molecular pathways
characterized in pathology are also utilized by microglia in the normal and developing brain to influence
synaptic development and connectivity, and therefore should become targets of future research. Microglial
dysfunction results in behavioral deficits, indicating thatmicroglia are essential for proper brain function. This
defines a new role for microglia beyond being a mere pathologic sensor.Microglia Are the Cellular Response Element to
Pathology
Microglia are an integral part of CNS networks (Figure 1); micro-
glial cells form the innate defensive system of the CNS, and their
pathological potential has been extensively investigated (Ha-
nisch and Kettenmann, 2007; Kettenmann et al., 2011). All
CNS diseases involve microglia, which typically convert from
the resting/surveillant cell type in the normal brain to an activated
form specialized to operate within the diseased environment.
Microglial activation is classically characterized by two major
changes. First, the cell shape transforms from a highly branched
and ramified morphology to an amoeboid form, and second,
these amoeboid cells become active phagocytes. Recently, it
has become apparent that microglial activation is a process
more diverse and dynamic than has been considered previously
(Hanisch and Kettenmann, 2007). In different pathologies micro-
glia acquire distinct functional states and during the disease
progression microglial cells modify and change their activated
phenotype. Activatedmicroglia specifically interact with neurons
and influence their survival either in a positive or in a negative
direction. Microglia can physically contact injured neurons
and remove synapses, a process termed synaptic stripping;
in some instances, entire dendritic trees are eliminated. As
part of the activation routine microglial cells release diverse
substances such as reactive oxygen species, cytokines or
growth factors, which influence the pathological process during
the acute and chronic phase as well as during subsequent
regeneration.
Microglia Remove Synapses in Pathology: Discovery of
Synaptic Stripping
Microglia remove synapses from neuronal cell bodies. This pro-
cess was first recognized in the facial nerve injury model and
termed synaptic stripping (Blinzinger and Kreutzberg, 1968).
Lesion to the facial nerve that carries axons of motoneurons10 Neuron 77, January 9, 2013 ª2013 Elsevier Inc.located in the facial nucleus, triggers microglial activation, man-
ifested by upregulation of cytokines, cell adhesion molecules,
extracellular matrix proteins, transcription factors, and proteins
of the major histocompatibility complex. Activated micro-
glial cells release neurotrophic factors such as nerve growth
factor (NGF), neurotrophin (NT)-4/5, transforming growth factor
(TGF)-b1, glial-derived neurotrophic factor (GDNF), fibroblast
growth factor (FGF), and interleukin (IL)-3, which affect neuronal
survival (Nakajima et al., 2007). Microglia-derived factors also
include proinflammatory mediators such as tumor necrosis
factor (TNF)-a, IL-6, or nitric oxide (NO), which confer neurotox-
icity. Microglial secretory activity can vary depending on the
pathologic context (Hanisch and Kettenmann, 2007). In the facial
nerve lesion model microglial cells proliferate, migrate to and
interact with motoneurons ultimately removing synaptic input
to these cells (Moran and Graeber, 2004). In the rat facial nucleus
the response is exclusively restricted to intrinsic microglia and
does not involve invading blood cells such as macrophages or
lymphocytes. The phenomenon of synaptic stripping represents
a generic microglial response, which can also be activated in
other brain regions (e.g., in the cortex [Trapp et al., 2007]). In
certain pathologies, for example in prion disease, activation of
microglia proceeds without activation of synaptic stripping (Sis-
kova´ et al., 2009; Perry and O’Connor, 2010).
There are many factors, by which microglia sense neuronal
injury, including chemokines or small molecules like ATP.
Conceptually, two types of signals control microglial behavior
in response to injury: ‘‘find-me’’ signals attract microglial cells
to the damaged site, whereas ‘‘eat-me’’ signals allow microglia
to identify the target and trigger phagocytosis. Another classifi-
cation distinguishes between ‘‘on signaling,’’ which includes
factors newly appearing in the pathologic context or are upregu-
lated and ‘‘off signaling,’’ which includes factors that disappear
or are downregulated in pathology (Biber et al., 2007). Obser-
vations from vagal motoneurons additionally suggest that a
Figure 1. Uniform Distribution of Microglia
in the Central Nervous System
(A) Throughout the central nervous system
microglia (red) surveys neuronal networks (black)
and astroglial syncytia (blue). Both microglia
and astrocytes uniformly divide the gray matter
through a process called tiling in which individual
microglial cells and astrocytes only minimally
overlap in the three-dimensional space. However,
processes of one cell type can strongly overlap
with territories of the other cell type. While
astrocytes are part of rather stable structure-
functional elements known as neurovascular
units, microglial processes constantly scan
through their territorial domains and establish
frequent transient contacts with neighboring
neurons and astrocytes.
(B) The panel shows a laser-scanning micrograph
taken from an adult TgH(CX3CR1-EGFP) mouse
brain in which microglia is labeled by expression
of EGFP. Note the uniform cellular distribution
within and across different brain regions such as
cortex (ctx), corpus callosum (cc), and hippo-
campus (hip).
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initiate) synaptic stripping (Yamada et al., 2008).
Microglial Cells Can Sense Neuronal Activity
Studies in cell culture indicated that microglial cells express
a variety of receptors for neurotransmitters, neuropeptides,
and neuromodulators and thus have the capacity to sense
neuronal activity (Pocock and Kettenmann, 2007). For example,
cultured microglia express adrenergic receptors, metabotropic
and ionotropic glutamate and g-aminobutyric acid (GABA) re-
ceptors, dopamine receptors, bradykinin receptors, and several
types of purinoceptors; for some of these receptors functional
expression was corroborated by experiments in situ, as it has
been shown for serotonin, purinergic, endothelin-1, histamine,
substance P, and GABAB receptors (Kettenmann et al., 2011;
Krabbe et al., 2012; Seifert et al., 2011). So far, the expression
of these receptors in microglia has only been studied in acute
brain slices where the microglial activation process is already
initiated. It is conceivable, however, that microglial cells in the
unperturbed brain already express many (if not all) of such
receptors. The cell culture studies show that stimulation of
receptors to neurotransmitters, neuropeptides, and neuromo-
dulators affect microglial function instigating cytokine release,
movement of processes in response to injury or phagocytosis
(Kettenmann et al., 2011). For the inhibitory transmitter GABA
an anti-inflammatory action on microglia has been suggested
(Lee et al., 2011). Partial activation of both GABAA and GABAB
receptors renders microglia less responsive to inflammatory
stimuli such as lipopolysaccharide (LPS) and interferon-g (Lee
et al., 2011). Although a diversity of transmitter receptors has
been described on microglia, so far we lack experimental
proof that these receptors are activated during synaptic trans-
mission. Studies taking advantage of microglia-selective gene
knockout models or microglia-specific functional rescue exper-iments in a constitutive knockout background may resolve this
issue.
‘‘Resting’’ Microglia Are Active Cellular Elements
Migration of myeloid cells into the nervous tissue occurred early
in the evolution of the nervous system, and microglia-like
elements responsive to pathological insults are present in
ganglia of annelids (e.g., leech) and in mollusks. In vertebrates,
the development of the CNS is associated with a significant
increase in the density of parenchymal microglia, which account
for 10% of the total brain cell population in mammals (Lawson
et al., 1990; Mittelbronn et al., 2001). After entering the brain,
myeloid cells undergo remarkable remodeling that change their
structural appearance and physiology. Microglia acquire a
specific morphology (a small cell body endowed with several
extra-thin and highly motile processes) a state, which was
termed ‘‘resting microglia.’’ By experiencing this profound meta-
morphosis, microglia adapts to the neural environment, and,
as we will discuss later, become an integral part of the neural
circuitry (see also Figure 1), essential for CNS development,
(re)modeling, and physiological plasticity. It is also important
to remember that microglial cells display significant mor-
phological heterogeneity between brain regions (Olah et al.,
2011), whereas their functional heterogeneity awaits detailed
investigation.
A paradigm shift from recognizing microglia only as ‘‘resting’’
cells waiting for pathology, occurred when microglial process
motility was directly observed in the living mouse by in vivo
two-photon laser-scanning microscopy. In these experiments
microglial cells were imaged in the brain through either a cranial
window or a thinned scull, thus keeping CNS tissue undisturbed
(Davalos et al., 2005; Nimmerjahn et al., 2005). These obser-
vations revealed that microglial processes are arguably the fast-





BA Figure 2. Dynamic Interaction of Microglial
Processes with the Tripartite Synapse
(A) Microglial processes (red) dynamically contact
the cellular compartments of the tripartite syn-
apse: pre- and postsynaptic neuronal terminals (in
brown) as well as the enwrapping perisynaptic
astroglial process (in blue).
(B) The electron micrograph (EM) specifically
shows a microglial process (m) contacting both
the pre- and postsynaptic compartment. The EM
image is modified from Wake et al. (2009).
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thereby voiding the concept of microglia as a resting element.
In a retinal slice preparation Fontainhas et al. (2011) provided
evidence that neural activity mediated by GABAergic and gluta-
matergic mechanism regulate this movement of processes.
They conclude, however, that the motility control of microglial
processes is mediated through a purinergic signaling cascade.
In the in vivo experiments by Davalos et al. (2005) it was evi-
dent that lowering extracellular ATP concentration by the
ATP-hydrolyzing enzyme apyrase results in reduced process
movements, whereas artificially created ATP gradients stimulate
their motility. The metabotropic P2Y12 purinoceptors were found
to be responsible for that type of movement control (Haynes
et al., 2006).
Microglial Cells Contact Synapses in the Normal Brain
In the absence of pathological insults the highly dynamic sur-
veillant motility of microglia is specifically targeted to synaptic
structures (Figure 2). In the somatosensory and visual cortex
two-photon microscopy revealed that the microglial processes
make brief, repetitive contacts with synapses at a frequency of
about once per hour. These interactions were visualized by
in vivo two-photon imaging in the Iba-1-EGFP/Thy-1-GFP
double-transgenic mice in which microglial cells and neuronal
structures can be simultaneously visualized. Wake et al. (2009)
reported that the microglial processes appear in a close prox-
imity to presynaptic boutons, where they remain for about
5 min and then retract. These structural interactions are
activity-dependent, as their frequency was reduced by
decreased neuronal activity following either binocular eye en-
ucleation, injection of tetrodotoxin into both retinae or a reduc-
tion of body temperature (Wake et al., 2009). By combining
two-photon in vivo imaging with immunohistochemistry and
three-dimensional reconstructions obtained from serial section
electron micrographs (Figure 2B), a rather specific apposition
of microglial processes to pre- as well as postsynaptic compart-
ments was found in the visual cortex of juvenile mice (Tremblay
et al., 2010). Process extrusions were typically associated with
small and transiently growing dendritic spines. Again, neuronal
activity modulated microglial behavior: light deprivation reduced
the motility of microglial processes and increased their associa-
tion with larger dendritic spines. Re-exposure to light reversed12 Neuron 77, January 9, 2013 ª2013 Elsevier Inc.these behaviors and microglial processes
enwrapped synapses more extensively
(Tremblay et al., 2010). Thus microglial
cells respond to altered sensory experi-ence and it remains an open question whether the interactions
play any role in experience-dependent modification or elimina-
tion of synapses, in the developing as well as in the adult CNS.
Molecular cues that attract microglial processes to the synapses
remain largely unknown, although ATP and purinoceptors are
good potential candidates.
Microglia Release Substances that Can Affect Neurons
Conceptually, microglial cells can affect neural networks either
through removal of cellular and subcellular elements (by phago-
cytosis) or through secreting various factors with transmitter,
trophic or neuroprotective properties. The variety of neuroactive
agents that microglial cells can secrete has been mainly studied
in cell culture, an environment that triggers transformation of
microglial cells into an activated state. Thus, these factors are
considered to be pathological signals, which include several
types of cytokines (e.g., TNF-a or ligands for receptors such as
CCR1, 3, 5, and 7 and CXCR1 or 3), trophic factors like brain
derived neurotrophic factor (BDNF), the gaseous transmitter
NO or neurotransmitters (ATP and glutamate) (for review, see
Kettenmann et al. [2011]). Some of these substances were re-
ported to rapidly modulate neuronal function by changing excit-
ability and synaptic strength. Meanwhile, several factors known
from pathology, can mediate the interactions of microglia with
synapses in the healthy brain.
Recent findings indicate that some of these ‘‘pathological’’
factors mediate neuron-microglia crosstalk in the developing
or uninjured adult brain. Fraktalkine and complement receptors
can mediate synaptic pruning, whereas TNF-a affects synaptic
scaling. These processes represent only the beginning of new
discoveries of factors that mediate neuron-microglia crosstalk
in the normal brain. The fact that most of microglia-derived
factors are considered to be pathological may reflect global up-
regulation in response to pathology. In a physiological context
the upregulation of some factors may be structurally confined
to distinct sites within the microglial cell (at sites where they
interact with neuronal structures) or confined to a small popula-
tion of microglia that is engaged in a defined interaction with
neurons. This could be the reason why some of these neuron-
microglia signaling factors have so far remained undetected,






Figure 3. Synaptic Pruning by Microglial
Processes
(A) The stability and maintenance of presynaptic
terminals and postsynaptic spines is determined
by microglia in a three-step process called
synaptic pruning composed of contact, engulf-
ment, and phagocytosis of presynaptic terminals.
Whether dendritic spines are similarly removed by
microglia is still unclear.
(B) The electron microphotograph shows ultra-
structural interactions between microglia (red) and
synapses (brown) in themouse visual cortex. In the
thickened microglial process inclusions (in) can be
recognized (modified from Tremblay et al. [2010]).
The asterisks indicate extended extracellular
space adjacent to the microglia. Thin processes of
perisynaptic astrocytes are shown in light blue.
The arrowhead points toward a synaptic cleft.
Scale bar = 250 nm.
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Pruning during Development
The first wave of microglial ancestors, the primitive myeloid
progenitors originating from the extra-embryonic yolk sac, enter
the nervous tissue very early in embryonic development, being in
essence the first glial cells in existence (as both astrogliogenesis
and oligodendrogliogenesis occur later in a perinatal period)
(Ginhoux et al., 2010). This initial migration coincideswith the first
wave of embryonic synaptogenesis (which occurs, in rodents,
around embryonic day 14–15) that proceeds in the absence of
astrocytes (which assist and are indispensable for postnatal
formation of synapses). In this phase microglia can assist and
even promote early synaptogenesis through secretion of growth
factors. During later, pre- and postnatal development, microglial
processes actively engulf synaptic structures and exert a major
role in controlling the number of synapses through synaptic
pruning (Figure 3). The chemokine fractalkine plays a role in
chronic pain, inflammation, and Alzheimer’s disease and is
released by neurons and endothelial cells (Clark and Malcangio,
2012; Ransohoff et al., 2007). In the brain, fractalkine recep-
tors are expressed specifically by microglia and fractalkine
receptor-driven EGFP expression has become a reliable marker
for identifying microglial cells (Jung et al., 2000). In mice deficient
for this receptor, there is a transient increase in the spine density
during development, suggesting an underlying deficit in synaptic
pruning. Depletion of fractalkine receptor also increased the
frequency of miniature excitatory postsynaptic currents re-
corded in the hippocampus. This demonstrates that deficits in
microglia function result in synaptic changes (Paolicelli et al.,
2011). It could be speculated that a microglial dysfunction could
be responsible for developmental disorders, which result in
autistic conditions and psychiatric diseases such as schizo-
phrenia. In disease models, fractalkine receptor deficiency
conveys neurotoxicity. This was observed following peripheral
lipopolysaccharide injections, in a toxic model of Parkinson
disease and a transgenic model of amyotrophic lateral sclerosis
(Cardona et al., 2006). Importantly the physiological and patho-
logical phagocytosis showmorphological specificity: the phago-
cytosis of synaptic material or apoptotic cells is performed
without affecting the ramifiedmicroglial phenotype, bymicroglialprocesses or ‘‘en passant’’ branches forming ‘‘ball-and-chain’’
structures (Sierra et al., 2010). The phagocytic activity of ramified
microglia can be recorded in acute slices and seems to repre-
sent a constitutive behavior. Amoeboid microglia in situ also
extend processes that identify and phagocyte the pathogenic
material, although these processes have a velate appearance
quite different from processes in ramified microglia. Despite
this structural distinction the underlying molecular mechanisms
may be similar. Incidentally it is differently regulated in early post-
natal and adult microglia since only in early postnatal microglia
the phagocytic activity is controlled by serotonin (Krabbe et al.,
2012). The molecular cues regulating the synaptic pruning and
elimination during visual experience still have to be identified.
Receptors of the Complement Cascade Play a Role in
the Removal of Synapses by Microglia
Members of the complement cascade likeC5a orC3a are sensed
by cultured microglial cells and trigger an activated phenotype
(Ilschner et al., 1996). TheC1q complex also acts as an activation
signal for cultured microglial cells because it shifts these cells
toward a proinflammatory phenotype manifested by the release
of IL-6, TNF-a, and NO as well as an induction of an oxidative
burst similar to the proinflammatory response of microglia to
LPS (Fa¨rber et al., 2009). Recently, C1q has been identified as
an important factor for controlling synaptic pruning in the devel-
oping nervous system. During development, C1q is expressed
by neurons and localized to synapses throughout the postnatal
CNS and retina (Stevens et al., 2007). The authors speculate
that C1q serves as a tag for synapses that need to be eliminated.
Microglial cells engulf presynaptic inputs during peak retinogeni-
culate pruning around postnatal day 5, a time point when the
phagocytic activity ofmicroglia is high. The response ismediated
by the complement receptor 3 (CR3, composed of CD11b and
CD18 integrins) because the phagocytic activity was lower in
animals deficient for that receptor, and genetic deletion resulted
in deficits in synaptic connectivity (Schafer et al., 2012).
Microglia Regulate Synaptic Plasticity
Several studies indicate that microglial cells can influence syn-
aptic plasticity. Examples range from modulation of the NMDANeuron 77, January 9, 2013 ª2013 Elsevier Inc. 13
Figure 4. Microglial Regulation of Synaptic Plasticity in
a Multicellular Network
Microglial cells constitutively release different cytokines. This release is highly
sensitive to environmental condition and can be augmented over several
14 Neuron 77, January 9, 2013 ª2013 Elsevier Inc.
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Perspectivereceptor glycine binding site by microglia (Hayashi et al., 2006),
signaling by fractalkine and its receptor (Paolicelli et al., 2011;
Rogers et al., 2011), modulation of Cl gradient in neurons
through microglial BDNF release (Coull et al., 2005) and puriner-
gic signaling (Tsuda et al., 2010). The best documented role of
microglia in controlling neural network functions, however,
comes from the analysis of TNF-a effects on synaptic connec-
tivity. TNF-a is a proinflammatory cytokine, which is released
by microglial cells. Rise in TNF-a is a hallmark of acute and
chronic neuroinflammation as well as various neuropathological
developments including ischemic stroke, Alzheimer’s and Par-
kinson’s diseases, amyotrophic lateral sclerosis, and multiple
sclerosis (McCoy and Tansey, 2008). Under physiological condi-
tions, the low levels of TNF-a (acting at about 100 picomolar
concentrations) is a potent effector of synaptic scaling (Pascual
et al., 2012; Stellwagen and Malenka, 2006), a uniform adjust-
ment in the strength of all synapses formed on a given neuron
in response to prolonged changes in the electrical activity. Incu-
bating hippocampal slices with TNF-a increased the ratio of
AMPAR- to NMDAR-mediated synaptic currents without affect-
ing long-term potentiation (LTP) or long-term depression (LTD).
By using cocultures of neurons and glia from wild-type or
TNF-a knockout mice, the source of TNF-a was attributed to
glia. Thus, by modulating TNF-a levels, neuroglia actively par-
ticipate in the homeostatic activity-dependent regulation of
synaptic connectivity (Stellwagen and Malenka, 2006).
More recent data (Pascual et al., 2012) demonstrate that the
TNF-a is exclusively generated by microglia, and not by the
astrocytes. The scaling effect of TNF-a is mediated by activation
of astroglial TNF receptor I (TNFR I) (Bezzi et al., 2001; Domercq
et al., 2006). Microglial TNF-a and microglial ATP act in concert
to trigger adjacent astrocytes to release ATP. Astroglial ATP
subsequently amplifies themicroglial signal and promotes astro-
glial release of glutamate that directly affects synaptic trans-
mission through presynaptic metabotropic glutamate receptors
(Figure 4 and Pascual et al., 2012). These experiments per-
formed in the hippocampus provide important insights into the
complexity of neural circuits. Similar regulatory mechanisms
probably exist in the developing brain, for example in the
developing visual cortex. After monocular visual deprivation,
the reduction in response of binocular neurons to one eye is
matched by a corresponding increase to the other. In mice
deficient in TNF-a the increase in response to the open eye is
absent, thereby suggesting an experience- and TNF-a-depen-
dent mechanism (Kaneko et al., 2008). A similarly complex inter-
action of microglial ATP release, purinergic receptor activation,orders of magnitude. Enhanced microglial TNF-a release has been shown to
stimulate the release of glutamate and/or ATP from adjacent astrocytes.
Subsequently, these compounds can act pre- and postsynaptically to
strengthen synaptic transmission in a process called synaptic scaling.
(A) Baseline level of microglia function during network activity.
(B) Stimulation of microglia results in astroglial triggers of enhanced synaptic
activity. The mechanisms, however, how microglia perceive alterations of
synaptic activity have still to be uncovered.
(C) Microglial stimulation by LPS increases the firing rate of AMPAergic
synapses in acute hippocampal slices of the mouse brain. Insets show
representative traces before and after LPS application. The EPSP frequency
has been recorded from voltage-clamped pyramidal neurons. Modified from
Pascual et al. (2012).
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described in lower vertebrates namely in zebrafish, though
during the onset of an acute injury (Sieger et al., 2012).
Microglia Regulate Adult Neurogenesis
In the adult rodent brain, two neurogenic niches localized in the
subventricular zone and the dentate gyrus of the hippocampus
produce new neurons. There are conflicting findings as to the
role of microglia in regulating neurogenesis. An attenuating influ-
ence of microglia is inferred from the finding that inflammation
impairs the ability of hippocampal neural stem cells to generate
new neurons and this ability can be restored by anti-inflamma-
tory drugs such as indomethacin (Monje et al., 2003). In contrast,
the in vitro data indicate that microglial cells promote neurogen-
esis. Supernatant frommicroglial cultures endorses the ability of
stem cells to self-renew and to form multipotent neurospheres
(Walton et al., 2006). Hippocampal neurogenesis induced by
an exposure to the enriched environment was associated with
the recruitment of T cells and the activation of microglia (Ziv
et al., 2006), which further supports the facilitating role of micro-
glia. In the adult hippocampus microglia contributes to the regu-
lation of network activity by controlling the integration of newly
born neurons into the existing circuits and elimination of supra-
numerous, apoptotic neurons (Sierra et al., 2010).
Microglial Dysfunction Affects Behavior
Proper microglial function is a prerequisite for appropriate brain
function and constitutive activity of microglial cells seems to be
important for maintenance of neuronal circuitry and control of
behavior. There are two intriguing findings illustrating that selec-
tive dysfunction of microglia leads to abnormal behavior or
neural dysfunction. The first example is a mouse model of Rett
syndrome, a form of autistic disorder characterized by im-
paired synaptogenesis resulting in severe disturbances ofmotor,
language, and cognitive functions. These deficits correlate with
decreased size of neurons, reduced dendritic branching, and
reduced number of spines. The disease is linked to mutations
in the gene for methyl CpG binding protein 2 (MECP2), a tran-
scriptional repressor probably expressed in all cell types of the
brain. Mice with deletion of MECP2 exhibit impaired locomotor
function and a reduced life span. Microglia deficient in MECP2
show a strong reduction in phagocytic activity. Interestingly,
the phenotype ofMECP2 knockoutmice can be partially rescued
by selective expression of MECP2 in cells of the monocytic
lineage, including microglia. Thus, constitutive microglial phago-
cytic activity appears to be essential for the development or
maintenance of neuronal circuitry (Derecki et al., 2012).
Another brain dysfunction related to microglia is the patholog-
ical grooming behavior in Hoxb8-deficient mice. These mice are
used as a model for a compulsive hair pulling human disorder
also known as trichotillomania. In the mouse model, the behav-
ioral phenotype can be rescued by transplanting wild-type bone
marrow cells into these mutant mice. It is assumed that the bone
marrow derived monocytes populate the brain and transform
into cells with microglial properties. The rescue experiment by
bone-marrow grafting in adult mice suggest that this is not
a developmental defect, but may reflect dysfunction of microglia
in the adult animals (Chen et al., 2010).Microglial Dystrophy Contributes to Brain Aging
There is increasing evidence for microglial senescence that may
contribute to overall brain aging and age-associated cognitive
decline. Advanced age affectsmicroglial phenotype by changing
their morphology (deramification, increase of the cell body, frag-
mentation of the cytoplasm, formation of cytoplasmic spheroids,
etc.). These changes in microglial morphology are apparently
global and occur throughout the nervous system (Lopes et al.,
2008; Streit et al., 2004). This has also been thoroughly analyzed
in the auditory and visual cortex indicating that microglial density
increased resulting in smaller territories of individual cells. More-
over aged microglia have a more variable cell body and process
morphology (Tremblay et al., 2012). These dystrophic microglial
cells also display functional abnormalities manifested by slower
process motility and impaired reactions to local injury (Damani
et al., 2011). The dystrophic microglia is arguably less capable
in protecting CNS homeostasis and may promote neurodegen-
erative processes. In the absence of pathology dystrophic
microglia can contribute to overall weakening of synaptic con-
nectivity and plasticity, which generally underlie age-dependent
cognitive decline. These age-dependent alterations further high-
light the importance of microglia for normal brain function.
Microglia Modulate Neuronal Networks: Further
Lessons from Pathology
As discussed above there aremany potential factors known from
pathology, which can mediate neuron-microglia crosstalk (Fig-
ure 5).We also speculate that many factors have remained unde-
tected since they may be restricted to small subpopulations of
microglia or even small compartment(s) of the microglial cell. In
astrocytes for example, signaling often appears inmicrodomains
restricted to small areas within processes (Grosche et al., 1999).
Below, we present three examples, so far studied only in pa-
thology,which showhowmicroglia canaffect neuronal networks.
Is CCL21/CXCR3 Interaction Relevant for Removal of
Dendrites by Microglia?
Neurons damaged by glutamate excitotoxicity rapidly express
and secrete the chemokine CCL21; the latter is packaged into
vesicles, transported to presynaptic structures, and released
through exocytosis (de Jong et al., 2005). Microglial cells
express CXCR3 receptors specific for CCL21. Stimulation of
microglia with CCL21 triggers chemotaxis and increases migra-
tory activity (Biber et al., 2001). This neuron-microglia crosstalk
has been studied in the entorhinal cortex lesion model. When
the projections from the entorhinal cortex to the dentate gyrus
of the hippocampus are severed, the input parvalbumin-positive
interneurons undergo degeneration of their dendritic tree, the
latter being located in the molecular layer. Microglial cells are
attracted to that site. When, however, the CXCR3 receptor is
genetically deleted, microglial cells are not recruited anymore
and the dendritic trees of the interneurons remain intact (Rappert
et al., 2004). This finding indicates that removal of synaptic struc-
tures is an active process that involves microglia and a chemo-
kine signaling cascade.
When Do Microglial Cells Contribute to Glutamate
Clearance?
One important function of astrocytes is the removal of excess
glutamate by the activity of glutamate transporters. It is assumedNeuron 77, January 9, 2013 ª2013 Elsevier Inc. 15
Figure 5. Neuron-Microglia and Astrocyte-Microglia Signaling
Pathways in Pathology and Physiology
This scheme provides a highly simplified list of signaling pathways that have
been described in vitro or in vivo. The magenta box highlights many of those
that have been identified in pathology only. The green box, in contrast, indi-
cates signaling pairs with demonstrated functions at physiological conditions.
Most of the transmitter receptor signaling, however, has not yet been asso-
ciated with a disease or confirmed to be present in physiology (for details see
Kettenmann et al. [2011] and Kettenmann and Ransom [2012]).
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activity is transported into astrocytes. This ensures low levels
of extracellular glutamate and is a prerequisite for maintaining
transmitter homeostasis (Danbolt, 2001). Under pathologic con-
ditions, microglial cells upregulate the glutamate transporter
GLT-1 (EAAT-2), which is claimed to play a role in glutamate
clearance (van Landeghem et al., 2001). This was first described
in the facial nerve injury model. The induced expression of gluta-
mate transporter suggests a neuroprotective role of microglia
against glutamate excitotoxicity following nerve axotomy (Lo´-
pez-Redondo et al., 2000).
Under What Conditions Can Microglial BDNF Regulate
GABAergic Signaling?
Microglial cells are capable to modulate synaptic transmission
by secreting factors that affect synaptic responses. In an animal
model of neuropathic pain, activation of P2X4 receptors on spinal
cord microglia stimulates release of BDNF (Trang et al., 2011;
Tsuda et al., 2010). BDNF, in turn, causes a depolarizing shift16 Neuron 77, January 9, 2013 ª2013 Elsevier Inc.in the chloride reversal potential in spinal lamina I neurons thus
reversing the direction of GABAA receptor mediating currents.
As a result, microglia-derived BDNF converts inhibitory GABA/
glycine responses into excitatory ones thereby affecting the
excitability of the neuronal network. Interfering with purinergic
signaling or attenuating microglial BDNF release reduced symp-
toms of neuropathic pain. BDNF from spinal microglia is there-
fore a critical microglia-neuron signaling molecule that gates
aberrant nociceptive processing in the spinal cord (Trang et al.,
2011; Tsuda et al., 2010). It is tempting to speculate that similar
mechanisms also exist in the healthy brain, e.g., during plastic
events that occur in learning and memory formation.
Conclusion
Substantial evidence has been accumulated that show the wide
potential of microglia to sense various activities of their adjacent
cellular neighbors, of neurons as well as astrocytes or microglia
themselves. Processes of astrocytes as well as microglia are
in close proximity to synapses. While astroglial contacts are
considered to be a more permanent component of the ‘‘tripartite
synapse,’’ microglial processes are much more dynamic and
display only transient interactions.
In particular, microglia fulfills their function in shaping the brain
during development and plasticity. In addition, its strength as
an environmental sensor and powerful provider of cytokines,
growth factors or transmitters establishes microglia as a potent
and far-reaching regulator of the extended neuron-glia network.
This further advances the doctrine regarding the brain as a multi-
cellular circuitry in which all cell types are acting in concert to
achieve the most effective information processing and decision
making.
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